第一单位：
Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
作者：
Raquel Carvalho,Montenegro [1]
;
Alison,Howarth [2]
;
Alessandro,Ceroni [2]
;
Vita,Fedele [2]
;
Batoul,Farran [3]
;
Felipe Pantoja,Mesquita [1]
;
Martin,Frejno [4]
;
Benedict-Tilman,Berger [5]
;
Stephanie,Heinzlmeir [6]
;
Heba Z,Sailem [7]
;
Roberta,Tesch [5]
;
Daniel,Ebner [2]
;
Stefan,Knapp [5]
;
Rommel,Burbano [8]
;
Bernhard,Kuster [9]
;
Susanne,Müller [10]
作者单位：
Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
[1]
Novo Nordisk Research Centre Oxford (NNRCO), Discovery Technologies and Genomics, Oxford, UK.
[2]
Winship Cancer Institute, Emory University, Atlanta, GA, USA.
[3]
Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
[4]
Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe-University Frankfurt, Frankfurt, Germany.;Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Frankfurt, Germany.
[5]
Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
[6]
Institute of Biomedical Engineering, Department of Engineering, University of Oxford, Oxford, UK.;Big Data Institute, University of Oxford, Li Ka Shing Centre for Health Information and Discovery, Old Road Campus Research Building, Oxford, UK.
[7]
Ophir Loyola Hospital, Belém, PA, Brazil.
[8]
Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.;Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technische Universität München, Freising, Germany.
[9]
Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe-University Frankfurt, Frankfurt, Germany.
[10]
DOI
10.18632/oncotarget.27462
PMID
32082487
发布时间
2025-05-30
换一批
